CNS-5161

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCNS-5161
Drug Alias NameCNS-5161
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsCancer PainNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPaion Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPaion Pharma
Active IndicationsN/A
Inactive IndicationsCancer PainNeuralgia

Other Information

ATC CodeN/A
Related LinksDrugBank